Biomarkers associated with COVID-19 disease progression

G Ponti, M Maccaferri, C Ruini, A Tomasi… - Critical reviews in …, 2020 - Taylor & Francis
… to coronavirus disease 2019 (COVID-19) disease progression, in order to stratify high risk
patients. The rapid disease … who will suffer rapid disease progression to severe complications …

Clinical manifestation and disease progression in COVID-19 infection

PH Tsai, WY Lai, YY Lin, YH Luo, YT Lin… - Journal of the …, 2021 - journals.lww.com
… from early stage of COVID-19 patient according to CT scans. Hence, CT scan provides a
rapid evaluation of progression and severity of COVID-19. However, COVID-19 pneumonia and …

Risk factors for disease progression in COVID-19 patients

MC Chang, YK Park, BO Kim, D Park - BMC infectious diseases, 2020 - Springer
COVID-19 patients who were discharged to home after complete cure. The transferred group
included COVID-19 … infectious disease hospital due to COVID-19 progression to severe …

[HTML][HTML] Role of hematological parameters in the stratification of COVID-19 disease severity

S Taj, SA Fatima, S Imran, A Lone, Q Ahmed - Annals of medicine and …, 2021 - Elsevier
… to investigate the association of hematological parameters with COVID-19 disease, and to
evaluate the role of hematological parameters in stratification of COVID-19 disease severity. …

Sex differences in immune responses that underlie COVID-19 disease outcomes

T Takahashi, MK Ellingson, P Wong, B Israelow… - Nature, 2020 - nature.com
… Although our study provides a strong basis for further investigation into how COVID-19
disease dynamics may differ between male and female patients, it is important to note that there …

Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease

M Li, W Guo, Y Dong, X Wang, D Dai, X Liu… - Frontiers in …, 2020 - frontiersin.org
… patients from Wuhan Union hospital, one of the designated hospitals for the treatment of
COVID-19, were included in this study along with 37 age-matched healthy volunteers. Patients’ …

Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study

J Tian, X Yuan, J Xiao, Q Zhong, C Yang, B Liu… - The Lancet …, 2020 - thelancet.com
… determine risk factors of COVID-19 disease severity for patients with cancer and COVID-19. …
We found that the odds of COVID-19 progressing into severe illness was 3·611 times higher …

The hallmarks of COVID-19 disease

D Tang, P Comish, R Kang - PLoS pathogens, 2020 - journals.plos.org
… There is currently no specific treatment for COVID-19, but antiviral therapy combined … progress
in understanding the epidemiological, virological, and clinical characteristics of COVID-19

Immune suppression in the early stage of COVID-19 disease

W Tian, N Zhang, R Jin, Y Feng, S Wang, S Gao… - Nature …, 2020 - nature.com
… We subdivided the 14 COVID-19 patients into nine with moderate disease type and five with
severe disease type according to the information provided by the attending physicians at the …

SnoRNAs and miRNAs networks underlying COVID-19 disease severity

A Parray, FA Mir, A Doudin, A Iskandarani… - Vaccines, 2021 - mdpi.com
… the peripheral blood of severe COVID-19 cases (n = 9), as compared to mild (n = 10) and
asymptomatic (n = 10) patients. This study analyzed a total of 29 COVID-19 patients that were …